CureLab Oncology

CureLab Oncology is a biotechnology company developing new anti-cancer biologics. CureLab Oncology is committed to creating a series of revolutionary therapies for cancer patients to help extend their lives. CureLab Oncology's main product, Elenagen™, is a plasmid (supercoiled circular DNA) encoding the p62/SQSTM1 gene. Elenagen™ can reverse tumor grading, alter the tumor microenvironment, enhance the anti-cancer effects of other therapies (such as chemotherapy), alleviate chronic inflammation, and stimulate an immune attack on tumors.